Healthcare

passed · New York · Senate Jan 27, 2026

S 1438: Enacts the New York state abortion clinical training program act

Establishes the New York state abortion clinical training program within the department of health for the purpose of training health care practitioners in the performance of abortion and related reproductive health care services; requires the commissioner of health to submit a report to the governor and the legislature.

Topics ✓ HealthcareSupports HealthcareEstablishes abortion clinical training program to expand reproductive healthcare access by training providers, directly advancing patient access to reproductive health services.90% confidence

Sub-Topics Women's Health

Track

passed · New York · Senate Mar 10, 2026

S 2400: Establishes a blood clot and pulmonary embolism policy workgroup

S 2400 creates a workgroup to study blood clots and pulmonary embolisms in the state. The workgroup, appointed by the governor and legislative leaders, will include healthcare providers, patients, family members, and advocates. It must study annual incidence rates, current data collection methods, patient impacts, care standards, emerging treatments, and develop a risk surveillance system. The workgroup will issue policy recommendations within one year to improve patient awareness, surveillance in healthcare facilities (like hospitals), and written risk notices for patients. These recommendations will be published by the health department after submission.

Topics ✓ HealthcareSupports HealthcareCreates workgroup to study blood clots/pulmonary embolisms, develop surveillance system, improve patient awareness - enhances healthcare policy and care standards85% confidence

Track

in committee · New York · Assembly Jan 7, 2026

A 4774: Restores medical futility as a basis for DNR

This bill (A 4774) restores a specific medical standard - defined as resuscitation being "unsuccessful in restoring cardiac and respiratory function or causing repeated arrests before death" - as a valid basis for issuing a do-not-resuscitate (DNR) order. It directly affects patients with irreversible conditions (e.g., terminal illness, permanent unconsciousness) who lack decision-making capacity, making it easier for medical teams to establish DNR orders without court approval under New York’s Family Health Care Decisions Act and Surrogate’s Court procedures. The key provision adds this "medical futility" criterion as an alternative to existing standards, clarifying when resuscitation would not be effective. This change simplifies the process for healthcare providers in end-of-life scenarios where treatment would not work.

Topics ✓ HealthcareSupports HealthcareRestores medical futility standard for DNR orders, enabling faster patient care decisions without court approval for irreversible conditions, aligning with patient rights in healthcare.90% confidence

Track

in committee · New York · Senate Jan 7, 2026

S 6295: Requires health insurance plans to provide coverage for epi-pens for individuals 18 years old and younger

This bill requires health insurance plans in New York to cover epi-pens (epinephrine auto-injectors) for individuals under 18 years old when medically necessary. It applies to all individual, group, and certain health corporation insurance policies delivered in the state. Insurers must provide this coverage upon request by the insured or covered person. The requirement takes effect 90 days after the bill becomes law and applies to new contracts or renewals after that date. This directly affects insurers and children/teens with severe allergies requiring emergency epinephrine treatment.

Topics ✓ HealthcareSupports HealthcareMandates insurance coverage for epi-pens under 18, expanding access to critical allergy treatment and protecting patient rights for medically necessary care.95% confidence

Sub-Topics Insurance

Track

in committee · New York · Assembly Jan 7, 2026

A 3833: Relates to capping cost sharing for antiviral COVID-19 therapeutics

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Topics ✓ HealthcareSupports HealthcareMandates no-cost coverage for FDA-approved antivirals, removing patient cost barriers and improving access to COVID-19 treatment.95% confidence

Sub-Topics Hospitals

Track

in committee · New York · Senate Jan 7, 2026

S 7594: Relates to requiring insurers participating in the NY state of health marketplace to offer at least one dental plan for individuals age 65 and older

Senate Bill S 7594 requires health insurers participating in the New York State of Health marketplace to offer at least one dental plan. This bill specifically mandates that these plans be available for individuals aged 65 and older. It amends current public health law to ensure that qualified or approved dental plans are offered through the state's health insurance marketplace. The bill aims to provide more dental coverage options for senior citizens.

Topics ✓ HealthcareSupports HealthcareMandates dental coverage expansion for seniors in NY health marketplace, directly increasing insurance options and access for vulnerable population95% confidence

Sub-Topics Public Health

Track

in committee · New York · Senate Jan 7, 2026

S 5421: Designates Xylazine as a schedule III depressant

This bill adds Xylazine (a veterinary sedative sometimes misused in human drug markets) to New York State's Schedule III list of controlled substances under public health law. Schedule III classification means Xylazine will now be regulated similarly to drugs like anabolic steroids, requiring prescriptions for medical use and imposing stricter controls on distribution. The law directly affects healthcare providers, pharmacies, and law enforcement by establishing new legal requirements for handling Xylazine. It takes effect 90 days after enactment, following its referral to the Health committee on February 21, 2025.

Topics ✓ HealthcareSupports HealthcareClassifies Xylazine under public health law to control misuse, directly addressing public health programs as defined in the topic.95% confidence

Sub-Topics Public Health

Track

passed · New York · Senate Jun 4, 2026

S 8426: Prevents discrimination by insurers based on an individual's mental health or substance use disorder

Prevents discrimination by insurers based on an individual's mental health or substance use disorder; incorporates into law federal enforcement rules set forth in the federal mental health parity and addiction equity act of 2008.

Topics ✓ HealthcareSupports HealthcarePrevents insurer discrimination against mental health/substance use disorder patients, enforcing parity and protecting patient rights under federal law.95% confidence ✓ Labor & EmploymentSupports Labor & EmploymentPrevents insurer discrimination on mental health/substance use, ensuring equal access to benefits, aligns with expanding worker benefits under employment standards.85% confidence

Sub-Topics Mental Health Substance Abuse

Track

in committee · New York · Assembly Jan 7, 2026

A 5354: Requires health insurers to provide coverage without cost-sharing for opioid antagonists and devices

Requires health insurers to provide coverage without cost-sharing for opioid antagonists and devices; provides that no prior authorization of premedical review for coverage of such opioid antagonist is required.

Topics ✓ HealthcareSupports HealthcareMandates insurers cover opioid antagonists without cost-sharing or prior authorization, improving access to overdose reversal treatments.95% confidence

Sub-Topics Substance Abuse

Track

in committee · New York · Assembly Jan 7, 2026

A 3769: Relates to the designation of an independent consumer assistance program

Relates to the designation of an independent consumer assistance program to assist consumers with the filing of complaints and appeals, track problems, educate consumers, assist uninsured, insured, or underinsured consumers in accessing appropriate health care services, assist with enrollment and provide other health insurance assistance.

Topics ✓ HealthcareSupports HealthcareAssists uninsured/underinsured in accessing healthcare services and enrollment, directly improving patient access and support per bill summary.95% confidence

Sub-Topics Insurance

Track